Synermed®
- Primary DI
- 05060500091811
- Brand
- Synermed®
- Company
- INFRARED LABORATORY SYSTEMS LLC
- Model
- IR750-1200
- Catalog number
- IR750-1200
- Device description
- Direct Bilirubin Reagent 2 X 67 mL
- Published
- 2017-02-28
- Public version status
- Update
- Distribution status
- In Commercial Distribution
- MRI safety
- Labeling does not contain MRI Safety Information
- Rx
- true
Contact Domains#
Product Codes#
| Code | Name |
|---|---|
| CIG | Diazo Colorimetry, Bilirubin |
Product Code Classifications#
| Code | Device | Specialty | Class |
|---|---|---|---|
| CIG | Diazo Colorimetry, Bilirubin | Clinical Chemistry | 2 |
Premarket Submissions#
| Submission | Supplement |
|---|---|
| K973109 | 000 |
Premarket Details#
Identifiers And Packaging#
| Identifier | Type | Agency | Package quantity | Status |
|---|---|---|---|---|
| 05060500091811 | Primary | GS1 | 0 |
Alternate GTIN / UPC / EAN Codes
| Source identifier | GTIN-14 normalized | EAN-13 |
|---|---|---|
| 05060500091811 | 05060500091811 | 5060500091811 |
GMDN Terms#
| Term | Definition |
|---|---|
| Conjugated (direct) bilirubin IVD, reagent | A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the quantitative measurement of conjugated (direct) bilirubin in a clinical specimen. |
Storage And Handling#
| Type | Low | High | Condition |
|---|---|---|---|
| Storage Environment Temperature | 20 Degrees Celsius | 25 Degrees Celsius |
Sterilization Methods#
| Method |
|---|
Contacts#
| Phone | |
|---|---|
| 317 896-1565 | info@irlabsystems.com |
Regulatory Flags#
- DUNS number
- 014210494
- Device count
- 1
- Kit
- true
- Lot or batch
- true
- Expiration date on label
- true
Other Devices From This Company#
| Primary DI | Brand | Model | Catalog | Published |
|---|---|---|---|---|
| 05060500090029 | Synermed® | IR010-R | IR010-R | 2016-09-20 |
| 05060500090036 | Synermed® | IR010-X | IR010-X | 2016-09-20 |
| 05060500090043 | Synermed® | IR010-WK | IR010-WK | 2016-09-20 |
| 05060500090050 | Synermed® | IR010-911 | IR010-911 | 2016-09-20 |
| 05060500090067 | Synermed® | IR010-L | IR010-L | 2016-09-20 |
| 05060500091682 | Synermed® | IR010-1200 | IR010-1200 | 2017-02-28 |
| 05060500090739 | Synermed® | VI560-R | VI560-R | 2016-09-20 |
| 05060500090746 | Synermed® | VI5600-X | VI5600-X | 2016-09-20 |
| 05060500090753 | Synermed® | VI560-WK | VI560-WK | 2016-09-20 |
| 05060500090760 | Synermed® | VI560-911 | VI560-911 | 2016-09-20 |
| 05060500090777 | Synermed® | VI561-L | VI561-L | 2016-09-20 |
| 05060500090784 | Synermed® | VI562-L | VI562-L | 2016-09-20 |
| 05060500091873 | Synermed® | VI560-1200 | VI560-1200 | 2017-02-28 |
| 05060500090005 | Synermed® | IR-500 | IR-500 | 2016-09-20 |
| 05060500090012 | Synermed® | IR-1200 | IR-1200 | 2016-12-12 |
| 05060500091538 | Synermed® | IR954 | IR954 | 2016-09-20 |
| 05060500091545 | Synermed® | IR961-X | IR961-X | 2016-09-20 |
| 05060500091552 | Synermed® | IR962-X | IR962-X | 2016-09-20 |
| 05060500091590 | Synermed® | ISE530-K | ISE530-K | 2016-09-20 |
| 05060500091613 | Synermed® | 001 | 001 | 2016-09-20 |
Other Devices Sharing Product Codes#
| Primary DI | Brand | Company | Product code | Published |
|---|---|---|---|---|
| 07613336235508 | Bilirubin Total Gen.3 | Roche Diagnostics GmbH | CIG | 2025-02-04 |
| 07613336235515 | Bilirubin Total Gen.3 | Roche Diagnostics GmbH | CIG | 2025-01-31 |
| 07613336235522 | Bilirubin Total Gen.3 | Roche Diagnostics GmbH | CIG | 2025-01-31 |
| 00630414614755 | Atellica CH Diazo Direct Bilirubin (D_DBil) | Siemens Healthcare Diagnostics Inc. | CIG | 2024-10-16 |
| 00630414614922 | Atellica CH Diazo Total Bilirubin (D_TBil) | Siemens Healthcare Diagnostics Inc. | CIG | 2024-10-16 |
| 00630414313429 | Atellica CH Diazo Direct Bilirubin (D_DBil) | Siemens Healthcare Diagnostics Inc. | CIG | 2024-10-16 |
| 00630414313436 | Atellica CH Diazo Total Bilirubin (D_TBil) | Siemens Healthcare Diagnostics Inc. | CIG | 2024-10-16 |
| 00380740167561 | ARCHITECT | ABBOTT IRELAND | CIG | 2024-08-15 |
| 00380740167578 | ARCHITECT | ABBOTT IRELAND | CIG | 2024-08-15 |
| 00380740167585 | Alinity | ABBOTT IRELAND | CIG | 2024-08-15 |
| 00850053916045 | IDG/Sanzay | IDG/SANZAY Corporation | CIG | 2024-01-08 |
| 04015630924912 | Bilirubin Direct Gen.2 (Doumas standardization) | Roche Diagnostics GmbH | CIG | 2023-10-06 |
| 04015630927531 | Bilirubin Direct Gen.2 (Doumas standardization) | Roche Diagnostics GmbH | CIG | 2023-10-06 |
| 10673486001204 | Teco Diagnostics Direct Bilirubin TC-Matrix | TECO DIAGNOSTICS | CIG | 2023-07-21 |
| 10673486001211 | Teco Diagnostics Direct Bilirubin Reagent Set | TECO DIAGNOSTICS | CIG | 2023-07-21 |
| 10673486001280 | Teco Diagnostics Total Bilirubin TC Matrix | TECO DIAGNOSTICS | CIG | 2023-07-21 |
| 10673486001297 | Teco Diagnostics Total Bilirubin Reagent Set | TECO DIAGNOSTICS | CIG | 2023-07-21 |
| 10673486001303 | Teco Diagnostics Direct and Total Bilirubin Reagent Set | TECO DIAGNOSTICS | CIG | 2023-07-21 |
| 00852169008317 | ClearChem Diagnostics Inc. Total Bilirubin | CLEARCHEM DIAGNOSTICS INC. | CIG | 2023-01-20 |
| 00852169008324 | ClearChem Diagnostics Inc. Direct Bilirubin | CLEARCHEM DIAGNOSTICS INC. | CIG | 2023-01-20 |
| 00811727015952 | Pointe Total Bilirubin Reagent | HORIBA INSTRUMENTS INCORPORATED | CIG | 2021-01-30 |
| 00811727016133 | Pointe Direct Bilirubin Reagent | HORIBA INSTRUMENTS INCORPORATED | CIG | 2021-01-30 |
| 00811727016256 | Pointe Total Bilirubin Reagent | HORIBA INSTRUMENTS INCORPORATED | CIG | 2021-01-30 |
| 00842768014192 | Dimension® Flex® reagent cartridge URCA | Siemens Healthcare Diagnostics Inc. | CIG | 2020-09-24 |
| 03610230006870 | Yumizen C1200 Direct Bilirubin | HORIBA ABX SAS | CIG | 2020-08-28 |
| 03610230006887 | Yumizen C1200 Total Bilirubin | HORIBA ABX SAS | CIG | 2020-08-28 |
| 00811727015822 | Pointe Direct Bilirubin for BS480 | HORIBA INSTRUMENTS INCORPORATED | CIG | 2020-05-28 |
| 00380740174965 | ARCHITECT | Abbott GmbH | CIG | 2020-04-12 |
| 00380740174972 | ARCHITECT | Abbott GmbH | CIG | 2020-04-12 |
| 07613336164884 | Direct Bilirubin | Roche Diagnostics GmbH | CIG | 2020-03-13 |